Directed new share issue in Nordic Nanovector ASA (NO) — NOK 231 million

Carnegie acted as joint bookrunner in the directed new share issues of 13,228,670 new shares at a subscription price of NOK 17.50 per share. Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. September 2020.